Travis Morey, CADCII | |
6555 Abercorn St Ste 129, Savannah, GA 31405-5723 | |
(912) 335-1699 | |
(912) 335-1352 |
Full Name | Travis Morey |
---|---|
Gender | Male |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 6555 Abercorn St Ste 129, Savannah, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013453083 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | 749 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Travis Morey, CADCII 6555 Abercorn St Ste 129, Savannah, GA 31405-5723 Ph: (912) 335-1699 | Travis Morey, CADCII 6555 Abercorn St Ste 129, Savannah, GA 31405-5723 Ph: (912) 335-1699 |
News Archive
Approximately 15% of Asians living in New York City are chronically infected with hepatitis B virus, according to a new study by New York University School of Medicine researchers and their colleagues.
For nearly two decades following the 1991 Gulf War, doctors noticed a trend in many of veterans of that conflict: an unexplainable cluster of symptoms including but not limited to chronic fatigue, memory loss, and depression. It wasn't until 2008 that a scientific panel from the U.S. Department of Veterans Affairs concluded that a third of American troops who served in the Gulf War were suffering from combinations of these symptoms, now recognized collectively as Gulf War Illness (GWI).
Among homeless individuals cardiovascular disease remains one of the major causes of death due to challenges in predicting initial risk, limited access to health care and difficulties in long-term management, according to a review published today in the Journal of the American College of Cardiology.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
Vision researchers in Boston have published the second paper of a study designed to determine if a driver who suffers from loss of central vision is able to detect pedestrians in a timely manner when driving.
› Verified 2 days ago
Tye Walcott, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 125 Fahm St, Savannah, GA 31401 Phone: 912-344-9403 | |
Ms. E Delores Hughes, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 6400 Waters Avenue, Savannah, GA 31409 Phone: 912-345-0987 | |
Catherine Mcclure Miller, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 905 Reita St, Savannah, GA 31410 Phone: 904-477-1466 | |
Christadora Clymer, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 408 E Bolton St, Savannah, GA 31401 Phone: 912-713-1830 | |
Dr. Clayton Vance Martin, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 6711 Forest Park Dr, Savannah, GA 31406 Phone: 404-449-3028 | |
Alia Carata, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 5 Executive Cir, Savannah, GA 31406 Phone: 912-373-6346 |